FDA Drug Recalls

Recalls / Class II

Class IID-0522-2023

Product

Simvastatin Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9747-9

Affected lot / code info
Lot: C2222P, D1522L, E3122D, G2522J, Exp 9/30/2023; Lot: J1222R, Exp 10/31/2023.

Why it was recalled

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Recalling firm

Firm
Preferred Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1250 N Lakeview Ave Ste O, Anaheim, California 92807-1801

Distribution

Quantity
82 Bottles of 90 Tablets
Distribution pattern
USA Nationwide

Timeline

Recall initiated
2023-03-23
FDA classified
2023-04-06
Posted by FDA
2023-04-12
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0522-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.